This paper is in the following e-collection/theme issue:

Early Results from COVID-19 Studies (281) Registered Report (528) Infectious Diseases (non-STD/STI) (1490) Vaccination and Immunization in the Digital Age (347) Outbreak and Pandemic Preparedness and Management (1679)

Published on in Vol 6, No 11 (2022): November

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/41914, first published .
The Incidence and Effect of Adverse Events Due to COVID-19 Vaccines on Breakthrough Infections: Decentralized Observational Study With Underrepresented Groups

The Incidence and Effect of Adverse Events Due to COVID-19 Vaccines on Breakthrough Infections: Decentralized Observational Study With Underrepresented Groups

The Incidence and Effect of Adverse Events Due to COVID-19 Vaccines on Breakthrough Infections: Decentralized Observational Study With Underrepresented Groups

Authors of this article:

Irene S Gabashvili1 Author Orcid Image
Article Authors Cited by (1) Tweetations (59) Metrics

Books/Policy Documents

  1. Doke-Bagade P, Bagade O. Biosystems, Biomedical & Drug Delivery Systems. View